Refreshing results…
LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses
UploadClinical and Immunologic Features of Germline Pathogenic Variant–Positive Patients with Melanoma
UploadMissing publications? Search for publications with a matching author name.